Cargando…
Heterogeneity of the tumor vasculature: the need for new tumor blood vessel type-specific targets
Therapies directed against VEGF-A and its receptors are effective in treating many mouse tumors but have been less so in treating human cancer patients. To elucidate the reasons that might be responsible for this difference in response, we investigated the nature of the blood vessels that appear in...
Autores principales: | Nagy, Janice A., Dvorak, Harold F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484269/ https://www.ncbi.nlm.nih.gov/pubmed/22692562 http://dx.doi.org/10.1007/s10585-012-9500-6 |
Ejemplares similares
-
Targeting the tumor vasculature with TEM8-specific T cells
por: Williams, LaTerrica C, et al.
Publicado: (2014) -
Numerical modeling of nanodrug distribution in tumors with heterogeneous vasculature
por: Chou, Cheng-Ying, et al.
Publicado: (2017) -
Blood vessels as targets in tumor therapy
por: Claesson-Welsh, Lena
Publicado: (2012) -
Revisiting tumor angiogenesis: vessel co-option, vessel remodeling, and cancer cell-derived vasculature formation
por: Qian, Chao-Nan, et al.
Publicado: (2016) -
The tumor vasculature an attractive CAR T cell target in solid tumors
por: Akbari, Parvin, et al.
Publicado: (2019)